IRIDEX Corp (IRIX) Stock Analysis
Verdict: HOLD
Heavy insider buying and a deep P/S discount suggest a value floor, but path to $2.75 requires a shift from console sales to probe recurring revenue.
Investment score: 61/100
Analysis as of
Is IRIDEX Corp stock worth reviewing? AI model thesis
IRIX is an undervalued microcap medical device play characterized by extreme insider confidence and improving earnings surprises. While top-line growth is modest (7.7%), the pivot toward recurring probe revenue and the deep valuation discount relative to peers (P/S 0.34x vs FEMY 5.08x) present a compelling asymmetric risk/reward profile.
7-factor investment score
- Valuation: 85/100 (weight 20%)
- Financial Health: 40/100 (weight 15%)
- Technical Momentum: 45/100 (weight 15%)
- Earnings Quality: 75/100 (weight 15%)
- Insider Sentiment: 95/100 (weight 10%)
- Analyst Consensus: 80/100 (weight 10%)
- Risk-Adjusted Return: 40/100 (weight 15%)
IRIDEX Corp opportunities and risks
What speaks for IRIX
- Deep Relative Valuation Discount
What speaks against IRIX
- Liquidity and Dilution Risk
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| IRIX | n/a | 0.3x | n/a | 36.1% | -6.2% | -13.5% |
| MODD | n/a | 0.0x | n/a | 0.0% | 0.0% | -252.7% |
| FEMY | n/a | 5.1x | n/a | 53.1% | -521.8% | -153.8% |
| GIPL | n/a | 145.2x | n/a | 86.7% | -474.2% | -1.9% |
| GTHP | n/a | 19.0x | n/a | 67.9% | -512.6% | -9.3% |
| Peer median | n/a | 12.0x | n/a | 60.5% | -493.4% | -81.6% |
Frequently asked questions about IRIDEX Corp (IRIX)
Is IRIX stock a good investment?
The cached TradeMates AI model rates IRIDEX Corp as HOLD with an investment score of 61/100. IRIX is an undervalued microcap medical device play characterized by extreme insider confidence and improving earnings surprises. While top-line growth is modest (7.7%), the pivot toward recurring probe revenue and the deep valuation discount relative to peers (P/S 0.34x vs FEMY 5.08x) present a compelling asymmetric risk/reward profile. This is algorithmic model output, not personal investment advice.
Is IRIX stock a buy?
The TradeMates model verdict for IRIX is HOLD with an investment score of 61/100. Treat this as a model signal to review, not a personal buy recommendation.